Muscular Dystrophy: New Study To Examine Effect Of ED Drugs On Muscle Blood Flow
Main Category: Muscular Dystrophy / ALSAlso Included In: Erectile Dysfunction / Premature Ejaculation; Cardiovascular / Cardiology
Article Date: 26 Mar 2010 - 1:00 PST
| Patient / Public: | ![]() |
|
| Healthcare Prof: | ![]() |
3.5 (2 votes) |
A Cedars-Sinai Heart Institute cardiologist has been awarded a three-year, nearly $1 million grant from the Muscular Dystrophy Association (MDA) to study whether drugs used to treat erectile dysfunction could also be used to improve muscle blood flow and reduce fatigue in muscular dystrophy patients.
The study, led by Ronald G. Victor, M.D., associate director of the Cedars-Sinai Heart Institute, co-directed by Gail Thomas, Ph.D. and funded by the Muscular Dystrophy Association (MDA), is intended to build on recent findings published in the journal Nature showing beneficial effects of tadalafil (also known as Cialis) in mice with an animal version of Duchenne and Becker muscular dystrophy. Only two doses of tadalafil improved muscle blood flow, allowing the dystrophic mice to perform more exercise with less muscle injury.
Victor's new short-term clinical trial will move the testing from animals to human patients with Becker muscular dystrophy and examine the effects of acute tadalafil dosing on muscle blood flow during a bout of exercise. Patients will take two doses of tadalafil prior to exercising. Then doctors will measure whether muscles receive increased blood flow and therefore are better protected during exercise.
Duchenne muscular dystrophy is an inherited wasting disease characterized by weakness and progressive degeneration of the muscles -- including the heart muscle - and is caused by a genetic mutation of dystrophin, a protein vital to healthy muscles. Muscle degeneration usually begins in the legs and pelvis, but later affects the whole body. By age 10, most patients experience heart problems. By their early-teenage years, most people with Duchenne muscular dystrophy are in a wheelchair. Becker muscular dystrophy is a milder form of muscular dystrophy that typically is diagnosed in early-adulthood.
"This is an exciting next step in the research I have been doing for 25 years, because we don't need to create a new drug -- the drug already exists," Victor said. "We now have the opportunity to find out if tadalafil can offer some hope for improving the lives of patients and allow them to do more exercise with less muscle injury."
Victor's study is open to adult males 18 - 55 who have Becker muscular dystrophy as well as adult males who don't have it. The study includes includes hand grip exercise testing, measurements of muscle blood flow and oxygen delivery, and magnetic resonance imaging of the muscles.
Source:
Sally Stewart
Cedars-Sinai Medical Center
Visit our muscular dystrophy / als section for the latest news on this subject.
MLA
15 Feb. 2012. <http://www.medicalnewstoday.com/releases/183564.php>
APA
http://www.medicalnewstoday.com/releases/183564.php.
Please note: If no author information is provided, the source is cited instead.
|
Rate this article: (Hover over the stars then click to rate) |
Patient / Public: |
or |
Health Professional: |
Add Your Opinion
Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
![]()
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.




